Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia.
about
Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic DiseasesLaparoscopic splenectomy for primary immune thrombocytopenia: Current status and challengesThromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice.How we manage immune thrombocytopenia in the elderly.Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US.Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012.Laparoscopic Splenectomy for Benign Hematological Disorders in Adults: A Systematic Review.Splenectomy for Immune Thrombocytopenia: Down but not out.Splenectomy in ITP: we keep removing a healthy functional organ.Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia.Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia.Eltrombopag in immune thrombocytopenia: efficacy review and update on drug safety.
P2860
Q26778773-216913D1-32FB-4BCE-979A-283BF1FEC319Q28066579-CCB54548-62D2-463C-931D-FA29F75B36A5Q30250259-38177CC7-0331-42CE-851C-53D2358A2464Q33410348-852C621F-C339-48B5-BE8E-16485AC0D85FQ33416947-8E64E279-6B29-483C-BC87-040CD9892E3FQ33428724-A9364D81-941A-4804-910D-A4AF75EE7CC2Q33431371-CB787B5F-ED29-4149-B6CD-EC5C621BBAC9Q33433662-15646B91-941B-4933-A393-3B4D83377B99Q33439137-6EC80657-4CD6-4EAE-9FA5-79400B89036DQ33770732-57C1AE7A-E56B-4A52-A3EB-92B958C62166Q47754303-CB5DBF68-809F-4822-A01A-4223FDCA5B40Q48088532-04B5B390-67B7-422A-B117-16F2AE649066Q53394122-C1077947-497E-4BB0-81ED-A6423246976CQ53394126-7C12014C-D7C3-46C6-B5D9-7BCA37D1C63AQ54922450-50B0EDF3-0B5C-4E4F-91C5-9B903C6F3B96
P2860
Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Safety and efficacy of splenec ...... with immune thrombocytopenia.
@ast
Safety and efficacy of splenec ...... with immune thrombocytopenia.
@en
type
label
Safety and efficacy of splenec ...... with immune thrombocytopenia.
@ast
Safety and efficacy of splenec ...... with immune thrombocytopenia.
@en
prefLabel
Safety and efficacy of splenec ...... with immune thrombocytopenia.
@ast
Safety and efficacy of splenec ...... with immune thrombocytopenia.
@en
P2093
P2860
P356
P1476
Safety and efficacy of splenec ...... with immune thrombocytopenia.
@en
P2093
Abel Fernandez
Carlos Aguilar
Carmen Esteban
Erik de Cabo
Fernando Escalante
Fernando Ortega
Grupo de Trombosis y Hemostasia de Castilla y León
Ignacio Alberca
Jose R Gonzalez-Porras
Luis J Garcia-Frade
P2860
P304
P356
10.1111/EJH.12146
P577
2013-07-07T00:00:00Z